Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Increased Postoperative Complications in Bilateral Mastectomy Patients Compared to Unilateral Mastectomy: An Analysis of NSQIP Database Osman F, Saleh F, Corrigan M, Jackson T, Cil T. University of Toronto, Toronto, Canada Introduction • The rate of contralateral prophylactic mastectomy among women with unilateral breast cancer has increased • Incidence of contralateral breast cancer is very low • Post-operative complications: Bilateral > Unilateral? Method ACS- NSQIP Data 2007-2010 All Mastectomy Patients N= 20,322 HighOther Risk procedures Pre-operative Characteristics Two Sentinelcoding Node (Reconstruction, Ambiguous Axillary dissection etc.) Biopsy Code Steroids, Infections and Missing Data Dialysis, Etc. N=12, 714 N= 769 N= 1,426 N= 1194 Unilateral and Bilateral Mastectomies with SLNB 4,219 Unilateral Mastectomy with SLNB Bilateral Mastectomy with SLNB 3, 722 497 Results: Baseline Characteristics Unilateral Mastectomy and sentinel lymph node biopsy N (%) Bilateral Mastectomy and sentinel lymph node biopsy P-Value N = 4,219 3,722(88.2) 497 (11.8) N/A Mean Age ( SD) 64.2 (13.0) 58.6 (11.8) P<0.001 Hypertension 1,979 (50.1) 182 (39.1) P<0.001 N (%) ASA b P=0.020 ASA 1 177 (4.5) 26 (5.6) ASA 2 2,362 (59.8) 306 (65.8) ASA 3 1,363 (34.5) 130 (28.0) ASA 4 46 (1.2) 3 (0.7) Diabetic 509 (12.9) 37 (8.0) P<0.002 Mean BMI ( SD) c 28.4 (6.9) 29.2 (7.1) P=0.024 Coronary Artery disease 185 (4.7) 15 (3.2) P=0.193 COPD d 145 (3.7) 9 (1.9) P=0.060 ETOH e 49 (1.2) 5 (1.1) P=1.000 Smoker a 565 (14.3) 65 (14.0) P<0.846 Chemotherapyf 48 (1.2) 13 (2.8) P=0.011 Results Complication Unilateral Mastectomy and SLNB N (%) Bilateral Mastectomy OR (95% CI) and SLNB N (%) Overall Complications** 164 (4.2) 39 (7.6) 1.9 (1.3 –2.8) Wound ** 106 (2.9) 29 (5.8) 2.1 (1.3- 3.3) Infectious ** 29 (0.8) 11 (2.2) 2.9 (1.3- 6.0) Respiratory 5 (0.1) 0 (0.0) (0.0, 5.8) Thromboembolic 10 (0.3) 1 (0.2) 0.7 (0.0, 5.3) Renal 1 (0.03) 0 (0.0) N/A Neurologic 3 (0.1) 1 (0.2) 2.5 (0.04, 31.2) Cardiac 2 (0.1) 0 (0.0) 0.0 (0.0, 14.4) Bleeding 15 (0.4) 0 (0.0) 0.0 (0.0, 1.9) **P-value <0.05 Multivariable Analysis of Overall Complications OR (95% CI) P-Value Bilateral vs. Unilateral mastectomy with sentinel lymph node biopsy Age 1.9 (1.3- 2.8) 0.001 1.01 (1.00 - 1.02) 0.132 Diabetes 1.3 (0.9 - 1.9) 0.213 Smoker 2.2 (1.5 - 3.2) <0.001 Body Mass Index 1.1 (1.0 - 1.1) <0.001 Chronic obstructive pulmonary disease 1.3 (0.7 - 2.4) 0.495 Coronary artery disease 1.4 (0.8 - 2.5) 0.246 Hypertension 1.0 (0.7 - 1.4) 0.900 ASA 3 and 4* 1.0 (0.8 - 1.5) 0.721 Chemotherapy 0.9 (0.2- 3.8) 0.877 Limitations of the Study • Only Short-term outcomes (30-day) • Cancer stage not reported in NSQIP data • Procedural codes: CPM • No Reconstruction Conclusion • Bilateral mastectomy appears to be associated with an increased risk of overall post-operative wound and other infections. • Further studies are warranted to examine short term and long-term complications of CPM and whether these complications delay treatment.